Week of
April 14th
,
2024

What to watch

Startup BioOrbit uses the unique conditions of space to perfect the crystallization of proteins for drugs, a potential breakthrough for immunotherapy

American Richard Slayman receives the world's first successful transplant of a genetically modified pig kidney, offering new hope for those with end-stage renal disease.

NVIDIA is collaborating with healthcare startup Hippocratic AI to create AI healthcare agents (Polaris) capable of performing tasks traditionally done by nurses.

Week of
April 14th
,
2024

Week in review

Bristol Myers Squibb's schizophrenia drug demonstrates persistent symptom improvement inphase 3 trials

READ MORE

Roche is distributing AI sepsis risk prediction tool through its diagnostic platforms

READ MORE

AbbVie's Cereval shows strongest evidence yet for Parkinson's and motor fluctuations in phase 3 trial

READ MORE

AbbVie showcases the scientific work behind drug development in its new campaign

READ MORE

J&J announces partnerships with 100 community-led health organizations dedicated to eliminating disparities in healthcare for BIPOC people

READ MORE

AstraZeneca's Enhertu will be the first approved treatment for HER2-positive solid tumors

READ MORE

Takeda's subcutaneous Entyvio receives FDA approval in CD

READ MORE

Merck's Keytruda-Lynparza combo may be effective in Lung cancer

READ MORE

J&J reports strong sales number for Tecvayli, claiming a strong hold on multiple myeloma

READ MORE

Eli Lilly's weight loss product Zepbound could help patients overcome Sleep Apnea

READ MORE

AbbVie's RINVOQ gains expanded approval for Giant Cell Arteritis

READ MORE

AbbVie ranked top in immunology by physicians

READ MORE

AI/R&D

Gene suppression could protect brain cells from damage caused by a Traumatic brain injury

READ MORE

Customizable treatment C18combinations may be the future of obesity

READ MORE

Barinthus Biotherapeutics HPV-related cancer therapy shows safety but not efficacy

READ MORE

Other

Doctors choose generic drugs over branded ones primarily due to lower price

READ MORE

On-going US drug shortage reaches new heights

READ MORE